HH Biotechnology Holdings Company
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HHBT research report →
Companywww.greatchinaholdings.com
HH Biotechnology Holdings Company engages in health and green industries. It focuses on planting and supplying macadamia nuts for use in foods, cooking oils, healthy products, toiletries, and cosmetics. The company was formerly known as Great China International Holdings, Inc.
- CEO
- Sheng Jiang
- IPO
- 2005
- Employees
- 121
- HQ
- Shenyang, CN
Price Chart
Valuation
- Market Cap
- $1.41K
- P/E
- 0.00
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- -0.95
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 29.45%
- Op Margin
- 38.78%
- Net Margin
- 30.99%
- ROE
- 8.78%
- ROIC
- -112.64%
Growth & Income
- Revenue
- $7.99M · 0.00%
- Net Income
- $2.48M · 0.00%
- EPS
- $0.18 · 0.00%
- Op Income
- $3.10M
- FCF YoY
- 0.00%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 4.08
- Avg Volume
- 3.85K
Get TickerSpark's AI analysis on HHBT
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our HHBT Coverage
We haven't published any research on HHBT yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate HHBT Report →